Coming Soon

press@xaira.com

Press

Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D

Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs

Why VC legend Bob Nelsen is making the biggest initial bet of his 37-year career on Xaira

Exclusive: Marc Tessier-Lavigne on leaving Stanford and joining biotech’s new AI mega-startup

Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development